{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:23:02Z","timestamp":1770276182651,"version":"3.49.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2021.13172","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T07:18:47Z","timestamp":1639984727000},"source":"Crossref","is-referenced-by-count":11,"title":["High expression of lncRNA <i>HSD11B1\u2011AS1<\/i> indicates favorable prognosis and is associated with immune infiltration in cutaneous melanoma"],"prefix":"10.3892","volume":"23","author":[{"given":"Kaiyuan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"key20220302121704_b1-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"h3074","DOI":"10.1136\/bmj.h3074","article-title":"US melanoma prevalence has doubled over past 30 years","volume":"350","author":"McCarthy","year":"2015","journal-title":"BMJ"},{"key":"key20220302121704_b2-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41467-020-15546-9","article-title":"Pre-clinical modeling of cutaneous melanoma","volume":"11","author":"Rebecca","year":"2020","journal-title":"Nat Commun"},{"key":"key20220302121704_b3-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S1470-2045(16)30578-2","article-title":"Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: A pooled analysis of individual patient data from randomised trials","volume":"17","author":"Long","year":"2016","journal-title":"Lancet Oncol"},{"key":"key20220302121704_b4-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"key20220302121704_b5-ol-23-02-13172","first-page":"201","article-title":"Diagnosis and treatment of melanoma","volume":"63","author":"Garbe","year":"2016","journal-title":"European consensus-based interdisciplinary guideline-Update 2016Eur J Cancer"},{"key":"key20220302121704_b6-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.critrevonc.2018.11.002","article-title":"Advanced stage melanoma therapies: Detailing the present and exploring the future","volume":"133","author":"Luther","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20220302121704_b7-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"key":"key20220302121704_b8-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12943-020-01206-5","article-title":"LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303\/PTBP3 axis","volume":"19","author":"Liang","year":"2020","journal-title":"Mol Cancer"},{"key":"key20220302121704_b9-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"e12506","DOI":"10.1111\/cpr.12506","article-title":"CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma","volume":"51","author":"Yu","year":"2018","journal-title":"Cell Prolif"},{"key":"key20220302121704_b10-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12935-020-01167-1","article-title":"Long non-coding RNA GAS5 accelerates oxidative stress in melanoma cells by rescuing EZH2-mediated CDKN1C downregulation","volume":"20","author":"Xu","year":"2020","journal-title":"Cancer Cell Int"},{"key":"key20220302121704_b11-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"e12457","DOI":"10.1111\/cpr.12457","article-title":"Long non-coding RNAs in melanoma","volume":"51","author":"Yu","year":"2018","journal-title":"Cell Prolif"},{"key":"key20220302121704_b12-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/ijms18040715","article-title":"Function and clinical implications of long Non-Coding RNAs in melanoma","volume":"18","author":"Richtig","year":"2017","journal-title":"Int J Mol Sci"},{"key":"key20220302121704_b13-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/1878-0261.12412","article-title":"Interplay between small and long non-coding RNAs in cutaneous melanoma: A complex jigsaw puzzle with missing pieces","volume":"13","author":"Riefolo","year":"2019","journal-title":"Mol Oncol"},{"key":"key20220302121704_b14-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature17161","article-title":"Melanoma addiction to the long non-coding RNA SAMMSON","volume":"531","author":"Leucci","year":"2016","journal-title":"Nature"},{"key":"key20220302121704_b15-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"643613","DOI":"10.3389\/fonc.2021.643613","article-title":"LncRNA POU3F3 contributes to dacarbazine resistance of human melanoma through the MiR-650\/MGMT Axis","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"},{"key":"key20220302121704_b16-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/pcmr.12926","article-title":"The tumour immune landscape and its implications in cutaneous melanoma","volume":"34","author":"Attrill","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20220302121704_b17-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"550987","DOI":"10.3389\/fonc.2020.550987","article-title":"Long noncoding RNAs, new critical regulators in cancer immunity","volume":"10","author":"Wu","year":"2020","journal-title":"Front Oncol"},{"key":"key20220302121704_b18-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1111\/cas.14634","article-title":"A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration","volume":"111","author":"Zhang","year":"2020","journal-title":"Cancer Sci"},{"key":"key20220302121704_b19-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41556-021-00672-3","article-title":"LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy","volume":"23","author":"Li","year":"2021","journal-title":"Nat Cell Biol"},{"key":"key20220302121704_b20-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/lary.28548","article-title":"Melanoma of the external auditory canal: A review of seven cases at a tertiary care referral center","volume":"131","author":"Appelbaum","year":"2021","journal-title":"Laryngoscope"},{"key":"key20220302121704_b21-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20220302121704_b22-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20220302121704_b23-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"key20220302121704_b24-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"key20220302121704_b25-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"key20220302121704_b26-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"key20220302121704_b27-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/pcmr.12537","article-title":"The emerging role of long non-coding RNAs in cutaneous melanoma","volume":"29","author":"Leucci","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20220302121704_b28-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12943-020-01150-4","article-title":"Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells","volume":"19","author":"Ma","year":"2020","journal-title":"Mol Cancer"},{"key":"key20220302121704_b29-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41420-019-0190-6","article-title":"Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFbeta and focal adhesion kinase (FAK) signaling","volume":"5","author":"Vishnubalaji","year":"2019","journal-title":"Cell Death Discov"},{"key":"key20220302121704_b30-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"key20220302121704_b31-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"e143296","DOI":"10.1172\/JCI143296","article-title":"Interferons in cancer immunoediting: Sculpting metastasis and immunotherapy response","volume":"131","author":"von Locquenghien","year":"2021","journal-title":"J Clin Invest"},{"key":"key20220302121704_b32-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3389\/fimmu.2018.01414","article-title":"Interferon signaling is frequently downregulated in melanoma","volume":"9","author":"Alavi","year":"2018","journal-title":"Front Immunol"},{"key":"key20220302121704_b33-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"key":"key20220302121704_b34-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1038\/sj.onc.1203523","article-title":"The role of Stat5a and Stat5b in signaling by IL-2 family cytokines","volume":"19","author":"Lin","year":"2000","journal-title":"Oncogene"},{"key":"key20220302121704_b35-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"e202149","DOI":"10.1001\/jamanetworkopen.2020.2149","article-title":"Association of long noncoding RNA biomarkers with clinical immune subtype and prediction of immunotherapy response in patients with cancer","volume":"3","author":"Yu","year":"2020","journal-title":"JAMA Netw Open"},{"key":"key20220302121704_b36-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820139.2021.1989461","article-title":"LncRNA CRNDE exacerbates IgA nephropathy progression by promoting NLRP3 inflammasome activation in macrophages","volume":"7","author":"Shen","year":"2021","journal-title":"Immunol Invest"},{"key":"key20220302121704_b37-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/pcmr.12371","article-title":"Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma","volume":"28","author":"Lad\u00e1nyi","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20220302121704_b38-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00262-007-0286-3","article-title":"Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor","volume":"56","author":"Lad\u00e1nyi","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"key20220302121704_b39-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: Impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"key20220302121704_b40-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.ajpath.2014.07.003","article-title":"B cells promote tumor immunity against B16F10 melanoma","volume":"184","author":"Kobayashi","year":"2014","journal-title":"Am J Pathol"},{"key":"key20220302121704_b41-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.humpath.2016.03.022","article-title":"Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome","volume":"54","author":"Garg","year":"2016","journal-title":"Hum Pathol"},{"key":"key20220302121704_b42-ol-23-02-13172","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/cells9020417","article-title":"Human plasmacytoid dendritic cells and cutaneous melanoma","volume":"9","author":"Monti","year":"2020","journal-title":"Cells"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T10:19:47Z","timestamp":1646216387000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2021.13172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,20]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2021.13172","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]},"article-number":"54"}}